27 Publikationen in 2018
Kumulativer IF: 225.7
Mittelwert IF: 8.36

1. Mitochondrial and contractile function of human right atrial tissue in response to remote ischemic conditioning
Kleinbongard P, Gedik N, Kirca M, Stoian L, Frey U, Zandi A, Thielmann M, Jakob H, Peters J, Kamler M, Heusch G
JAHA; 7:e009540    (Impact Factor = 4,66)

2. Vago-Splenic Axis in Signal Transduction of Remote Ischemic Preconditioning in Pigs and Rats.
Lieder HR, Kleinbongard P, Skyschally A, Hagelschuer H, Chilian WM, Heusch G
Circ Res; 123:1152-1163    (Impact Factor = 15,862)

3. Translation, Translation, Translation - The Need for Large Animal Studies in Cardioprotection Research
Heusch G, Skyschally A, Kleinbongard P
Circ Res; 123:931-933    (Impact Factor = 15,862)

4. The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology.
Davidson SM, Arjun S, Basalay MV, Bell RM, Bromage DI, Bøtker HE, Carr RD, Cunningham J, Ghosh AK, Heusch G, Ibanez B, Kleinbongard P, Lecour S, Maddock H, Ovize M, Walker M, Wiart M, Yellon DM
Basic Res Cardiol; 113:43    (Impact Factor = 6,47)

5. Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients.
Dannenberg L, Petzold T, Achilles A, Naguib D, Zako S, Helten C, M'Pembele R, Mourikis P, Podsvyadek Y, Grandoch M, Levkau B, Zeus T, Kelm M, Hohlfeld T, Polzin A
Eur J Clin Pharmacol; 75:13-20    (Impact Factor = 2,774)

6. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.
Bøtker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femminò S, García-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhäuser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schlüter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G
Basic Res Cardiol; 113:39    (Impact Factor = 6,47)

7. Lessons learned from the german aortic valve registry
Hamm CW, Mohr F, Heusch G
J Am Coll Cardiol; 72:689-692    (Impact Factor = 18,693)

8. Comparison of lipoprotein(a)-levels in patients ≥70 years of age with versus without aortic valve stenosis.
Mahabadi AA, Kahlert P, Kahlert HA, Dykun I, Balcer B, Forsting M, Heusch G, Rassaf T
Am J Cardiol; 122:645-649    (Impact Factor = 2,843)

9. Methylene Blue Treatment of Grafts During Cold Ischemia Time Reduces the Risk of Hepatitis C Virus Transmission.
Helfritz FA, Bojkova D, Wanders V, Kuklinski N, Westhaus S, von Horn C, Rauen U, Gallinat A, Baba HA, Skyschally A, Swoboda S, Kinast V, Steinmann E, Heusch G, Minor T, Meuleman P, Paul A, Ciesek S
J Infect Dis; 218:1711-1721    (Impact Factor = 5,045)

10. Cardioprotection research must leave its comfort zone
Heusch G
Eur Heart J; 39:3393-3395    (Impact Factor = 24,889)

11. Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
Weske S, Vaidya M, Reese A, von Wnuck Lipinski K, Keul P, Bayer JK, Fischer JW, Flögel U, Nelsen J, Epple M, Scatena M, Schwedhelm E, Dörr M, Völzke H, Moritz E, Hannemann A, Rauch BH, Gräler MH, Heusch G, Levkau B
Nat Med; 24:667-678    (Impact Factor = 30,641)

12. Influence of long-term treatment with glyceryl trinitrate on remote ischemic conditioning.
Hauerslev M, Mørk SR, Pryds K, Contractor H, Hansen J, Jespersen NR, Johnsen J, Heusch G, Kleinbongard P, Kharbanda R, Bøtker HE, Schmidt MR
Am J Physiol Heart Circ Physiol; 315:H150-H158    (Impact Factor = 4,084)

13. Humoral transfer and intra-myocardial signal transduction of protection by remote ischemic perconditioning in pigs, rats, and mice.
Skyschally A, Kleinbongard P, Lieder HR, Gedik N, Stoian L, Amanakis G, Elbers E, Heusch G
Am J Physiol Heart Circ Physiol; 315: H159-H172    (Impact Factor = 4,084)

14. 25 years of remote ischemic conditioning: from laboratory curiosity to clinical outcome.
Heusch G
Basic Res Cardiol; 113:15    (Impact Factor = 6,47)

15. Platelet function testing: dead or alive.
Helten C, Naguib D, Dannenberg L, Pöhl M, Ayhan A, Hohlfeld T, Levkau B, Kelm M, Zeus T, Polzin A
J Thromb Haemost; 16:984-986    (Impact Factor = 4,662)

16. EURO-CRIPS: Another piece of evidence for systemic cardiovascular protection by remote ischemic conditioning.
Heusch G
Int J Cardiol; 257:30-31    (Impact Factor = 3,471)

17. Reflection of cardioprotection by remote ischemic perconditioning in attenuated ST-segment elevation during ongoing coronary occlusion in pigs: Evidence for cardioprotection from ischemic injury.
Kleinbongard P, Amanakis G, Skyschally A, Heusch G
Circ Res; 122:1102-1108    (Impact Factor = 15,862)

18. Structural basis of sterol binding and transport by a yeast StARkin domain.
Jentsch JA, Kiburu I, Pandey K, Timme M, Ramlall T, Levkau B, Wu J, Eliezer D, Boudker O, Menon AK
J Biol Chem; 293:5522-5531    (Impact Factor = 4,106)

19. Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila.
Joos JP, Saadatmand AR, Schnabel C, Viktorinová I, Brand T, Kramer M, Nattel S, Dobrev D, Tomancak P, Backs J, Kleinbongard P, Heusch G, Lorenz K, Koch E, Weber S, El-Armouche A
Sci Rep; 8:2940    (Impact Factor = 4,011)

20. Coronary microembolization and microvascular dysfunction.
Heusch G, Skyschally A, Kleinbongard P
Int J Cardiol; 258: 17-23    (Impact Factor = 3,471)

21. Invasive treatment of NSTEMI patients in German Chest Pain Units – Evidence for a treatment paradox
Schmidt FP, Schmitt C, Hochadel M, Giannitsis E, Darius H, Maier LS, Heusch G, Voigtländer H, Mudra H, Gori T, Senges J, Münzel T
Int J Cardiol; 255:15-19    (Impact Factor = 3,471)

22. Guidelines for experimental models of myocardial ischemia and infarction.
Lindsey ML, Bolli R, Canty JM Jr., Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G
Am J Physiol Heart Circ Physiol; 314: H812-H838    (Impact Factor = 4,084)

23. Persistent Survival Benefit From Remote Ischemic Pre-Conditioning in Patients Undergoing Coronary Artery Bypass Surgery.
Kleinbongard P, Peters J, Jakob H, Heusch G, Thielmann M
J Am Coll Cardiol; 71:252-254    (Impact Factor = 18,693)

24. Protection of the human coronary circulation by remote ischemic conditioning
Heusch G
Int J Cardiol; 252:35-36    (Impact Factor = 3,471)

25. Fatal attraction - A brief pathophysiology of the interaction between atrial fibrillation and myocardial ischemia.
Lieder H, Breithardt G, Heusch G
Int J Cardiol; 254:132-135    (Impact Factor = 3,471)

26. STAT3 as a common signal of ischemic conditioning: a lesson on "rigor and reproducibility" in preclinical studies on cardioprotection.
Kleinbongard P, Skyschally A, Gent S, Pesch M, Heusch G
Basic Res Cardiol; 113:3    (Impact Factor = 6,47)

27. Aspirin Inhibits Platelet-Derived Sphingosine-1-Phosphate Induced Endothelial Cell Migration.
Polzin A, Knoop B, Böhm A, Dannenberg L, Zurek M, Zeus T, Kelm M, Levkau B, Rauch BH
Pharmacology; 101:72-75    (Impact Factor = 1,615)